Literature DB >> 17981738

Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies.

Reinaldo Naoto Takahashi1, Fabricio Alano Pamplona, Rui Daniel Schroder Prediger.   

Abstract

Over the last decade, adenosine receptors in the central nervous system have been implicated in the modulation of cognitive functions. Despite the general view that endogenous adenosine modulates cognition through the activation of adenosine A1 receptors, evidence is now emerging on a possible role of A2A receptors in learning and memory. The present review attempts to examine results reported in different studies using diverse animal models, to provide a comprehensive picture of the recent evidence of a relationship between adenosinergic function and memory deficits. The present data suggest that caffeine (a nonselective adenosine receptor antagonist) and selective adenosine A2A receptor antagonists can improve memory performance in rodents evaluated through different tasks. They might also afford protection against memory dysfunction elicited in experimental models of aging, Alzheimer's disease, Parkinson's disease and, in spontaneously hypertensive rats (SHR), a putative genetic model of attention deficit hyperactivity disorder (ADHD).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981738     DOI: 10.2741/2870

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  45 in total

1.  Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.

Authors:  Sílvia Oliveira; Ana Paula Ardais; Clarissa Ribeiro Bastos; Marta Gazal; Karen Jansen; Luciano de Mattos Souza; Ricardo Azevedo da Silva; Manuella Pinto Kaster; Diogo Rizzato Lara; Gabriele Ghisleni
Journal:  Purinergic Signal       Date:  2018-12-03       Impact factor: 3.765

Review 2.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 3.  Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.

Authors:  Annalisa Pinna
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

Review 4.  The behavioral pharmacology of effort-related choice behavior: dopamine, adenosine and beyond.

Authors:  John D Salamone; Merce Correa; Eric J Nunes; Patrick A Randall; Marta Pardo
Journal:  J Exp Anal Behav       Date:  2012-01       Impact factor: 2.468

5.  Differential actions of adenosine A1 and A2A antagonists on the effort-related effects of dopamine D2 antagonism.

Authors:  John D Salamone; Andrew M Farrar; Laura Font; Vatsal Patel; Devra E Schlar; Eric J Nunes; Lyndsey E Collins; Thomas N Sager
Journal:  Behav Brain Res       Date:  2009-03-03       Impact factor: 3.332

6.  The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists.

Authors:  Lila T Worden; Mona Shahriari; Andrew M Farrar; Kelly S Sink; Jörg Hockemeyer; Christa E Müller; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2008-12-02       Impact factor: 4.530

Review 7.  Dopamine/adenosine interactions involved in effort-related aspects of food motivation.

Authors:  John D Salamone; Merce Correa
Journal:  Appetite       Date:  2009-07-25       Impact factor: 3.868

8.  Differential Behavioral and Biochemical Responses to Caffeine in Male and Female Rats from a Validated Model of Attention Deficit and Hyperactivity Disorder.

Authors:  Fernanda Nunes; Daniela Pochmann; Amanda Staldoni Almeida; Daniela Melo Marques; Lisiane de Oliveira Porciúncula
Journal:  Mol Neurobiol       Date:  2018-03-20       Impact factor: 5.590

9.  Effects of ethanol and caffeine on behavior in C57BL/6 mice in the plus-maze discriminative avoidance task.

Authors:  Danielle Gulick; Thomas J Gould
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

10.  Systemic administration of the adenosine A(2A) agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.

Authors:  Susana Mingote; Mariana Pereira; Andrew M Farrar; Peter J McLaughlin; John D Salamone
Journal:  Pharmacol Biochem Behav       Date:  2008-01-17       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.